BDBM42536 2-(4-chloranylphenoxy)-N-[2-[(3-methylphenyl)methylsulfanyl]ethyl]ethanamide::2-(4-chlorophenoxy)-N-[2-[(3-methylbenzyl)thio]ethyl]acetamide::2-(4-chlorophenoxy)-N-[2-[(3-methylphenyl)methylsulfanyl]ethyl]acetamide::2-(4-chlorophenoxy)-N-[2-[(3-methylphenyl)methylthio]ethyl]acetamide::2-(4-chlorophenoxy)-N-{2-[(3-methylbenzyl)thio]ethyl}acetamide::MLS000574795::SMR000196229::cid_2285391

SMILES N#Cc1ccc(N2CCOc3cc(C(=O)N4CCC(F)(F)CC4)ccc32)cc1

InChI Key InChIKey=NVODQAJLMYVUPL-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 42536   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 42536BDBM42536(US12577217, Example 1-17)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent